Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 10 of 10 items.

" " Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
" " Distribution of NUVAXOVID with English-only Vial and Carton Labels
NUVAXOVID was authorized by Health Canada on February 17, 2022. In order to provide earlier access to NUVAXOVID in the context of the global pandemic, Novavax, Inc. will distribute product vials, cartons and package inserts that are in English only for a…
AlertHealth professional risk communication | 2022-02-23
" " PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
UPDATED INFORMATION - July 6, 2022 A new PAXLOVID dose pack for use in patients with moderate renal impairment (eGFR ≥30 to <60 mL/min) is now available with a distinct DIN: 02527804. Pfizer has introduced this new packaging configuration to…
AlertHealth professional risk communication | 2022-01-17
" " Bull Wipes All-Purpose Disinfectant Wipes(2021-03-01)
Bull Wipes All-Purpose Disinfectant Wipes(2021-03-01) Starting date: March 1, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source…
RecallHealth product recall | 2021-03-01
" " E-Fect (2021-01-07)
E-Fect (2021-01-07) Starting date: January 7, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type III Source of recall: Health Canada Issue…
RecallHealth product recall | 2021-01-07
" " Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone
Importation of German-labelled Hydromorphon Ethypharm Kalceks (Hydromorphone Hydrochloride Solution for Injection) due to Potential Shortage of Canadian-labelled HYDROmorphone…
AlertHealth professional risk communication | 2021-01-06
" " Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir Starting date: September 8, 2020 Posting date: September 15…
AlertHealth professional risk communication | 2020-09-15
" " Mirage Antibacterial Wipes (2020-08-08)
Mirage Antibacterial Wipes (2020-08-08) Starting date: August 8, 2020 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall:…
RecallHealth product recall | 2020-08-08
" " Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician. Starting date: April 25, 2020 Posting…
AlertInformation update | 2020-04-25
" " No scientific evidence that ibuprofen worsens COVID-19 symptoms
No scientific evidence that ibuprofen worsens COVID-19 symptoms Starting date: March 20, 2020 Type of communication: Information Update Subcategory: Drugs Source of recall:…
AlertInformation update | 2020-03-20
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.